Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion type Assertion NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_head.
- NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion wasGeneratedBy ECO_0000203 NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_provenance.
- NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion wasDerivedFrom befree-2016 NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_provenance.
- NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion SIO_000772 10720057 NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_provenance.
- NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion evidence source_evidence_literature NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_provenance.
- NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_assertion description "[The ret/PTC mutations were identified in 15 tumors (45%), including 8 PTC-1 (8 of 15, 53%), 2 PTC-2 (2 of 15, 13%), 2 PTC-3 (2 of 15, 13%), and 3 (3 of 15, 20%) combined PTC mutations (PTC-1 and PTC-2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278183.RAMvfkEyRRZWC5cD2aHw2-YRfBrNid5t_3DLczu8lDpVE130_provenance.